LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P50
Within normal range
vs 3Y Ago
-1.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-11.99%
Q2 2025-2.00%
Q1 2025-15.55%
Q4 2024-23.86%
Q3 20240.38%
Q2 202438.41%
Q1 202429.73%
Q4 2023-25.49%
Q3 2023-28.21%
Q2 2023-16.23%
Q1 2023-34.37%
Q4 202261.80%
Q3 20227.42%
Q2 2022-1.97%
Q1 2022-38.11%
Q4 2021-29.73%
Q3 202116.76%
Q2 202111.06%
Q1 202168.98%
Q4 2020-1777.54%
Q3 2020-157.93%
Q2 2020-830.50%
Q1 20200.00%